carbostyril has been researched along with Germinoblastoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allmer, C; Ansell, SM; Colgan, JP; Ding, H; Gupta, M; Habermann, TM; Hohl, R; Inwards, DJ; Johnston, PB; Kaufmann, SH; Kurtin, PJ; Link, BK; Loegering, D; Markovic, SN; Maurer, MJ; Micallef, IN; Nowakowski, GS; Peterson, K; Porrata, LF; Schneider, P; Tang, H; Thompson, CA; Weiner, G; Witzig, TE | 1 |
| Bergh, A; Björk, P; Ivars, F; Källberg, E; Leanderson, T; Liberg, D; Olsson, A; Roth, J; Vogl, T; Wikström, P | 1 |
| Itoh, T; Kawaguchi, S; Mitsumori, K; Sasaki, YF | 1 |
| Albertini, S; Chételat, AA; Gocke, E; Miller, B; Muster, W; Pujadas, E; Strobel, R | 1 |
| Drexler, HG; Fleckenstein, E; Uphoff, CC | 1 |
| Albertini, S; Chételat, AA; Gocke, E | 1 |
| Martin, M; Rink, L; Wellinghausen, N | 1 |
| Drexler, HG; Meyer, C; Uphoff, CC | 1 |
| Campbell, AK; Chin, SF; Davies, S; Errington, RJ; Smith, PJ; Wiltshire, M | 1 |
1 trial(s) available for carbostyril and Germinoblastoma
| Article | Year |
|---|---|
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Enzyme Inhibitors; Farnesyltranstransferase; Female; Humans; Lymphoma; Male; Middle Aged; Quinolones; Recurrence; Treatment Outcome; Young Adult | 2011 |
8 other study(ies) available for carbostyril and Germinoblastoma
| Article | Year |
|---|---|
S100A9 interaction with TLR4 promotes tumor growth.
Topics: Angiogenesis Inhibitors; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Calgranulin B; CD11b Antigen; Cell Proliferation; Down-Regulation; Humans; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Binding; Quinolines; Quinolones; Spleen; Toll-Like Receptor 4; Transforming Growth Factor beta | 2012 |
Genotoxic potential of quinolone antimicrobials in the in vitro comet assay and micronucleus test.
Topics: Anti-Infective Agents; Chromosome Aberrations; Comet Assay; DNA Damage; Humans; In Vitro Techniques; Lymphoma; Micronucleus Tests; Mutation; Quinolones; Tumor Suppressor Protein p53 | 2006 |
Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems.
Topics: Animals; Biotransformation; Cell Line; CHO Cells; Chromosome Aberrations; Cricetinae; Cricetulus; DNA Repair; Enzyme Inhibitors; Escherichia coli; Eukaryotic Cells; Hypoxanthine Phosphoribosyltransferase; Lymphoma; Mice; Micronucleus Tests; Microsomes, Liver; Molecular Structure; Mutagenesis; Mutagenicity Tests; Mutagens; Prokaryotic Cells; Quinolones; Rats; Saccharomyces cerevisiae; Salmonella typhimurium; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1995 |
Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril).
Topics: Anti-Bacterial Agents; Anti-Infective Agents; B-Lymphocytes; Cell Line; Culture Media; Culture Techniques; Decontamination; DNA, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Leukemia; Lymphoma; Mycoplasma; Polymerase Chain Reaction; Quinolones; RNA, Bacterial; T-Lymphocytes; Tumor Cells, Cultured | 1994 |
The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay).
Topics: Animals; Anti-Infective Agents; Carcinogens; Chromosome Aberrations; Ciprofloxacin; Cricetinae; DNA Damage; Fleroxacin; Fluoroquinolones; Gene Conversion; Lymphoma; Methoxsalen; Mice; Mitosis; Mutagenicity Tests; Mutagens; Mutation; Photosensitizing Agents; Quinolones; Saccharomyces cerevisiae; Salmonella; Tumor Cells, Cultured; Ultraviolet Rays | 1996 |
Zinc inhibits interleukin-1-dependent T cell stimulation.
Topics: Animals; Cells, Cultured; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-1; Interleukin-1 Receptor-Associated Kinases; Lymphocyte Activation; Lymphoma; Mice; Neoplasm Proteins; Protein Kinase Inhibitors; Protein Kinases; Quinolones; T-Lymphocytes; Tosyl Compounds; Tumor Cells, Cultured; Zinc | 1997 |
Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics.
Topics: Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Cell Culture Techniques; Ciprofloxacin; Culture Media; Diterpenes; Drug Resistance; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Leukemia; Lymphoma; Minocycline; Mycoplasma; Quinolones; Suspensions; Tumor Cells, Cultured | 2002 |
DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells.
Topics: Apoptosis; Cell Cycle; Chelating Agents; Cytoplasm; DNA Damage; Ethylenediamines; Etoposide; Fluorescent Dyes; Humans; Lymphoma; Nucleic Acid Synthesis Inhibitors; Osmolar Concentration; Quinolones; Subcellular Fractions; Tosyl Compounds; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Zinc | 2002 |